Sunday, May 16th

Last update:05:44:44 AM IST

Recent Posts:
Homearrow News and Events Year 2010 Company to start HIV drug trials - Atlanta Journal Constitution

Company to start HIV drug trials - Atlanta Journal Constitution

By Craig Schneider

The Atlanta Journal-Constitution

GeoVax Labs, Inc., a Smyrna-based biotechnology company that creates and tests HIV/AIDS vaccines, has been granted federal permission to begin a phase 1 clinical trial for a treatment for people infected with HIV.


The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.

The Phase 1 clinical trial will monitor safety while evaluating the ability of the vaccine to elicit protective immune responses in vaccinated participants.

The trial is based on the achievement of post-vaccine viral control in animal studies conducted in recently infected non-human primates at the Yerkes National Primate Research Center, affiliated with Emory University.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of 'Fair dealing' or 'Fair use'. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication's website.




Know Your Rights!

Link to Aarogya

aarogya logo


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion